These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 10470095)
61. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker. Roberts DJ; Haber D; Sklar J; Crum CP Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523 [TBL] [Abstract][Full Text] [Related]
62. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Loeb DM; Evron E; Patel CB; Sharma PM; Niranjan B; Buluwela L; Weitzman SA; Korz D; Sukumar S Cancer Res; 2001 Feb; 61(3):921-5. PubMed ID: 11221883 [TBL] [Abstract][Full Text] [Related]
63. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069 [TBL] [Abstract][Full Text] [Related]
64. Genotype/phenotype correlations in Wilms' tumor. Huff V Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067 [TBL] [Abstract][Full Text] [Related]
65. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1. Lee YI; Kim SJ DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146 [TBL] [Abstract][Full Text] [Related]
66. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor. Park S; Tomlinson G; Nisen P; Haber DA Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654 [TBL] [Abstract][Full Text] [Related]
69. Role of the WT1 gene in Wilms' tumour. Haber DA; Housman DE Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241 [TBL] [Abstract][Full Text] [Related]
70. Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor. Menke AL; Shvarts A; Riteco N; van Ham RC; van der Eb AJ; Jochemsen AG Cancer Res; 1997 Apr; 57(7):1353-63. PubMed ID: 9102224 [TBL] [Abstract][Full Text] [Related]
71. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient. Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370 [TBL] [Abstract][Full Text] [Related]
72. Transcriptional regulation by the Wilms' tumour suppressor protein WT1. Wagner KJ; Roberts SG Biochem Soc Trans; 2004 Dec; 32(Pt 6):932-5. PubMed ID: 15506928 [TBL] [Abstract][Full Text] [Related]
73. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells. Kirschner KM; Hagen P; Hussels CS; Ballmaier M; Scholz H; Dame C FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770 [TBL] [Abstract][Full Text] [Related]
74. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation. Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820 [TBL] [Abstract][Full Text] [Related]
75. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers. Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984 [TBL] [Abstract][Full Text] [Related]
76. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor. Tajinda K; Carroll J; Roberts CT Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530 [TBL] [Abstract][Full Text] [Related]
77. An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modelling. Kennedy D; Ramsdale T; Mattick J; Little M Nat Genet; 1996 Mar; 12(3):329-31. PubMed ID: 8589729 [TBL] [Abstract][Full Text] [Related]
78. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice. Smith SI; Down M; Boyd AW; Li CL Cancer Res; 2000 Feb; 60(4):808-14. PubMed ID: 10706085 [TBL] [Abstract][Full Text] [Related]
79. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties. Kim J; Lee K; Pelletier J Oncogene; 1998 Apr; 16(15):1973-9. PubMed ID: 9591781 [TBL] [Abstract][Full Text] [Related]
80. The tumor suppressor gene WT1 inhibits ras-mediated transformation. Luo XN; Reddy JC; Yeyati PL; Idris AH; Hosono S; Haber DA; Licht JD; Atweh GF Oncogene; 1995 Aug; 11(4):743-50. PubMed ID: 7651738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]